These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 266208)
21. Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin. Weiler JM; Yurt RW; Fearon DT; Austen KF J Exp Med; 1978 Feb; 147(2):409-21. PubMed ID: 624904 [TBL] [Abstract][Full Text] [Related]
22. Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B. Daha MR; Fearon DT; Austen KF Immunology; 1976 Nov; 31(5):789-96. PubMed ID: 992711 [TBL] [Abstract][Full Text] [Related]
23. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum. Whaley K; Thompson RA Immunology; 1978 Dec; 35(6):1045-9. PubMed ID: 83964 [TBL] [Abstract][Full Text] [Related]
24. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid. Vogt W; Schmidt G; Lynen R; Dieminger L J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510 [TBL] [Abstract][Full Text] [Related]
25. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor. Schreiber RD; Medicus RG; Gïtze O; Müller-Eberhard HJ J Exp Med; 1975 Sep; 142(3):760-72. PubMed ID: 1165475 [TBL] [Abstract][Full Text] [Related]
26. Guinea pig erythrocytes, after their contact with influenza virus, acquire the ability to activate the human alternative complement pathway through virus-induced desialation of the cells. Lambré CR; Kazatchkine MD; Maillet F; Thibon M J Immunol; 1982 Feb; 128(2):629-34. PubMed ID: 6459381 [TBL] [Abstract][Full Text] [Related]
27. Hemolysis of normal human erythrocytes by autologous serum complement. Kitamura H; Nagano A; Kitano E Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307 [TBL] [Abstract][Full Text] [Related]
28. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay. Harris CL; Pettigrew DM; Lea SM; Morgan BP J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573 [TBL] [Abstract][Full Text] [Related]
29. Initiation of C3 cleavage in the alternative complement pathway. Fearon DT; Austen KF J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512 [TBL] [Abstract][Full Text] [Related]
30. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway. Brade V; Bentley C; Bitter-Suermann D; Hadding U Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Gigli I; Fujita T; Nussenzweig V Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746 [TBL] [Abstract][Full Text] [Related]
32. The mechanism of activation of the alternative pathway of complement by cell-bound C4b. Farries TC; Steuer KL; Atkinson JP Mol Immunol; 1990 Nov; 27(11):1155-61. PubMed ID: 2247091 [TBL] [Abstract][Full Text] [Related]
33. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ; Ramsey J; Hammer CH; Frank MM J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833 [TBL] [Abstract][Full Text] [Related]
34. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function. Schreiber RD; Götze O; Müller-Eberhard HJ J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010 [TBL] [Abstract][Full Text] [Related]
35. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor. Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408 [TBL] [Abstract][Full Text] [Related]
36. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro. Weiler JM; Gleich GJ J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544 [TBL] [Abstract][Full Text] [Related]
37. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis. Whaley K; Ward D; Ruddy S Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507 [TBL] [Abstract][Full Text] [Related]
38. Activation of the alternative pathway of complement: efficient fluid-phase amplification by blockade of the regulatory complement protein beta1H through sulfated polyanions. Bitter-Suermann D; Burger R; Hadding U Eur J Immunol; 1981 Apr; 11(4):291-5. PubMed ID: 6454580 [TBL] [Abstract][Full Text] [Related]
39. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus. Whaley K; Schur PH; Ruddy S Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347 [TBL] [Abstract][Full Text] [Related]
40. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement. Farries TC; Lachmann PJ; Harrison RA Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]